SCULLEY JOHN - 26 Aug 2022 Form 4 Insider Report for Celularity Inc (CELU)

Role
Director
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
Issuer symbol
CELU
Transactions as of
26 Aug 2022
Transactions value $
$215,206
Form type
4
Filing time
30 Aug 2022, 20:52:25 UTC
Previous filing
15 Jul 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Options Exercise $215,206 +768,594 +21.26% $0.28 804,739 26 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Stock Option (Right to Buy) Options Exercise $0 -768,594 -100% $0* 0 26 Aug 2022 Class A Common Stock 768,594 $0.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include 36,145 restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of (i) July 13, 2023, such date being the one-year anniversary of the date of grant, and (ii) the next annual stockholder meeting; in each case subject to the Reporting Person's continuous service with the Issuer through such date
F2 This option is fully vested and exercisable.